Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Libid in Female Patients With Decrease or Loss of Sexual Desire
NCT03080298Phase 2Completed
- Start
- Mar 2016
- Primary completion
- Apr 2017
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of BP101 in hypoactive sexual desire disorder (HSDD). Started Mar 2016; status: completed.
02
Drugs
BP101
03
Conditions
hypoactive sexual desire disorder (HSDD)
Beyond the preview
Go deeper on NCT03080298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03080298.